The company's Plant Science Group drives innovation in biotechnology. Syngenta believes that this and other new technologies will become steadily more significant in meeting the forecasted doubling of global calorie demand over the next two decades. Responsible adoption of, and consumer confidence in, these technologies will require robust and harmonised regulatory systems based on sound science. This needs to go hand-in-hand with transparency and a frank and inclusive dialogue, to which Syngenta is committed.
In agriculture, biotechnology presents opportunities to develop products with advantages for farmers and consumers. Click here to go to the global Syngenta website for more information.
Biopharmaceuticals offer very promising area for development. In the future, more human medicines will depend upon complex and more efficacious biological molecules such as proteins and antibodies. Some of these can be best produced through synthesis in plants. A dedicated in-house biopharma team exists to focus on this emerging area of biotechnology. Click here for more information.
|
